Global Contrast Enhanced Ultrasound Market by Type (Non-targeted, Targeted), by End-use (Clinics, Hospitals), by Product (Equipment, Contrast Agents) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global contrast enhanced ultrasound market was valued at USD1.8 billion in 2020. It is expected to grow at 4.0% compound annual growth rate (CAGR), between 2021 and 2028. The market growth can be attributed to the introduction of inexpensive contrast agents, an increase in ultrasound procedural volume, as well as the incorporation of contrast imaging modes into ultrasound systems. Contrast enhanced ultrasound (CEUS), which is less expensive, more radiation-free and more patient-friendly, is also superior to other technologies. Market growth is expected to be accelerated by this technology. In the fight against COVID-19, it is crucial to integrate CEUS technology into Point-of-Care (PoC), diagnostics.

This has led to a growing use of contrast-enhanced ultrasonography, which is able to detect COVID-19-related pneumonia early. The demand for this procedure has grown rapidly due to an increase in lung ultrasonography procedures. This will likely increase as more people develop cardiovascular and gastrointestinal disease.

The most preferred method for assessing lung disease in COVID-19 patients was contrast enhanced ultrasound. These devices also served as a bedside imaging tool that measured perfusion impairment in the brain, kidney and lung of COVID-19 children. CEUS can detect lung damage even in the symptomatic phase COVID-19. There are many studies that have been done to evaluate the effectiveness of CEUS in detecting microthrombi in COVID-19 sufferers. These studies will likely increase the use of CEUS in the future.

Due to increasing patient referrals for CEUS, frequent monitoring of Left Ventricular Volume and Ejection Fraction is essential in determining the type and timing of treatment that will be offered to patients with Cardiovascular Disorders. The poor endocardial border definition means that patients' LV and/or LVEF values are often underestimated, despite the availability of ultrasound imaging techniques such as harmonic imaging. The market is expected to grow because of the growing demand for accurate and sensitive diagnostic tools that can quantitatively assess the ventricular volume in patients with cardiac disease.

As these areas are the most important for clinical application of contrast-enhanced ultrasonic systems, it is expected that there will be an increase in CVDs, liver and kidney diseases, gastrointestinal disorders, and other vascular diseases. According to WHO, CVDs are the leading cause for death worldwide. CVDs are responsible for the deaths of 17.9 million people each year. With an increasing prevalence of CVDs, including alcohol and tobacco, sedentary lifestyles, and poor diets, the incidence of CVDs is on the rise.

Product Insights

With a market share of 72.6%, the equipment segment was the dominant product segment in 2020. Market growth has been fueled by the introduction of advanced ultrasound units that include transducer technology and other nonlinear imaging techniques. To increase product usability and enhance diagnostic experience, manufacturers of ultrasound scanners are more likely to offer comprehensive ultrasound imaging solutions in one system.

The new technology of contrast-enhanced ultrasound is being used in all future ultrasound technologies. Mindray, for instance, launched the DC-90 ultrasound system in December 2019 with an integrated contrast-enhanced mode. In the future, segment growth will be fueled by increased investment from drug companies, universities, and ultrasound manufacturers in developing contrast imaging-specific ultrasound modes & agents.

Type Insights

With a revenue share exceeding 73%, the non-targeted segment of the CEUS market dominated in 2020. This is the most popular CEUS imaging technique. All approved ultrasound contrast agents can be used in non-targeted applications. They are used to increase diagnostic sensitivity, determine blood volume and flow, and distinguish between benign and malignant liver tumors. Because of their popularity, the majority of commercially available products were non-targeted contrast agent.

These devices are used to measure the perfusion of organs and assess vascularity in target lesions (liver/kidney). Market growth is expected to be driven by the increasing prevalence of chronic diseases such as cancer and liver cirrhosis. The 2019 National Survey on Drug Use and Health (NSDUH) revealed that 14.1 million Americans had an alcohol-related disorder. Excessive alcohol consumption is one of the main causes of liver damage. It is expected that the changing global population of alcohol drinkers will positively impact the demand for services in ultrasound contrast imaging.

End-use Insights

Hospitals dominated the market, accounting for more than 58% of the total revenue in 2020. There is a rising demand for CEUS in hospitals due to increasing emergency visits. Hospitals have the highest revenue share due to their large patient base and high-quality ultrasound equipment.

Contraindications to the use of contrast agents include: Contraindications include intra-arterial injections of contrast agents, which can cause serious complications for patients. The segment is expected to grow because of the increased availability of specialists in hospitals and technicians who are skilled in the handling of equipment and contrast agents.

Regional Insights

North America held the largest market share, with over 24% in 2020. Although CEUS imaging has been used for cardiac and abdominal imaging in North America over the years, its approval for diagnosis of liver lesions is drawing more attention. The market is expected to grow due to several training and education programs for radiologists and sonologists on the diagnostic and therapeutic uses of CEUS in this region.

The U.S. has established medical codes, payment procedures, and coverage policies for the provision of ultrasound services in hospitals, clinics, and ambulatory centers. Additionally, general practitioners and family doctors are eligible for reimbursements for the use of ultrasounds at their offices. This has led to an increase in the number ultrasound procedures in the U.S. The country is likely to see a rise in the incidence of CVDs, IBDs, and other conditions that can cause inflammation.

The fastest CAGR is expected to be in Asia Pacific over the forecast period due to rising healthcare spending, particularly in China and India. The lack of organized reimbursement policies and the price-sensitive population in emerging economies are expected to increase the demand for affordable procedures such as contrast-enhanced ultrasonography imaging. The market is expected to grow due to the increasing number of government initiatives to improve the healthcare infrastructure in the region.

Market Share Insights & Key Companies

To increase their market share, the key players are pursuing various business strategies such as product launches, mergers and acquisitions, joint ventures, partnerships, and joint ventures. Daiichi Sankyo and GE Healthcare negotiated an agreement in March 2020. In this agreement, Daiichi Sankyo will transfer Japan's marketing authorization rights to GE Healthcare Pharma and return Japan's exclusive marketing & developmental rights for four diagnostic imaging agents. The following are some of the most prominent players in contrast enhanced ultrasound markets:

• Lantheus Medical Imaging, Inc.

• General Electric

• Bracco Diagnostic

• Siemens Healthcare GmbH

• nanoPET Pharma GmbH

• ESAOTE SPA

• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

Up Market Research published a new report titled “Contrast Enhanced Ultrasound Market research report which is segmented by Type (Non-targeted, Targeted), by End-use (Clinics, Hospitals), by Product (Equipment, Contrast Agents), By Players/Companies Lantheus Medical Imaging Inc, nanoPET Pharma GmbH, Siemens Healthcare GmbH, General Electric, ESAOTE SPA, Bracco Diagnostic, Shenzhen Mindray Bio-Medical Electronics Co Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Contrast Enhanced Ultrasound Market Report Segments:

The market is segmented by Type (Non-targeted, Targeted), by End-use (Clinics, Hospitals), by Product (Equipment, Contrast Agents).

Contrast Enhanced Ultrasound Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Contrast Enhanced Ultrasound Market

Overview of the regional outlook of the Contrast Enhanced Ultrasound Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Contrast Enhanced Ultrasound Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Contrast Enhanced Ultrasound Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Non-targeted

                2. Targeted

                1. Clinics

                2. Hospitals

                1. Equipment

                2. Contrast Agents

9. Market scenario by region, sub-region, and country.
10. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
11. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
12. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Contrast Enhanced Ultrasound Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Contrast Enhanced Ultrasound Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.